DE2366609C2 - - Google Patents

Info

Publication number
DE2366609C2
DE2366609C2 DE2366609A DE2366609A DE2366609C2 DE 2366609 C2 DE2366609 C2 DE 2366609C2 DE 2366609 A DE2366609 A DE 2366609A DE 2366609 A DE2366609 A DE 2366609A DE 2366609 C2 DE2366609 C2 DE 2366609C2
Authority
DE
Germany
Prior art keywords
capa
antigen
gel
buffer
powder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE2366609A
Other languages
German (de)
English (en)
Inventor
Knut Bertil Dr.Med. Bromma Se Bjoerklund
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BONNIERFOERETAGEN STOCKHOLM SE AB
Original Assignee
BONNIERFOERETAGEN STOCKHOLM SE AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BONNIERFOERETAGEN STOCKHOLM SE AB filed Critical BONNIERFOERETAGEN STOCKHOLM SE AB
Application granted granted Critical
Publication of DE2366609C2 publication Critical patent/DE2366609C2/de
Expired legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Hospice & Palliative Care (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DE2366609A 1972-07-10 1973-07-03 Expired DE2366609C2 (enrdf_load_stackoverflow)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US27027372A 1972-07-10 1972-07-10

Publications (1)

Publication Number Publication Date
DE2366609C2 true DE2366609C2 (enrdf_load_stackoverflow) 1988-02-25

Family

ID=23030635

Family Applications (2)

Application Number Title Priority Date Filing Date
DE2366609A Expired DE2366609C2 (enrdf_load_stackoverflow) 1972-07-10 1973-07-03
DE2333740A Expired DE2333740C2 (de) 1972-07-10 1973-07-03 Verwendung eines Hämagglutinations-Hemmverfahrens zur Ermittlung von Krebs

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE2333740A Expired DE2333740C2 (de) 1972-07-10 1973-07-03 Verwendung eines Hämagglutinations-Hemmverfahrens zur Ermittlung von Krebs

Country Status (22)

Country Link
JP (2) JPS5817168B2 (enrdf_load_stackoverflow)
AR (1) AR197243A1 (enrdf_load_stackoverflow)
AT (1) AT336780B (enrdf_load_stackoverflow)
BE (1) BE802126A (enrdf_load_stackoverflow)
BR (1) BR7305142D0 (enrdf_load_stackoverflow)
CA (1) CA1039650A (enrdf_load_stackoverflow)
CH (1) CH617853A5 (enrdf_load_stackoverflow)
DD (2) DD113918A5 (enrdf_load_stackoverflow)
DE (2) DE2366609C2 (enrdf_load_stackoverflow)
DK (1) DK139898B (enrdf_load_stackoverflow)
ES (1) ES416726A1 (enrdf_load_stackoverflow)
FI (1) FI60567C (enrdf_load_stackoverflow)
FR (1) FR2191885B1 (enrdf_load_stackoverflow)
GB (2) GB1443054A (enrdf_load_stackoverflow)
IL (1) IL42594A (enrdf_load_stackoverflow)
IN (1) IN138903B (enrdf_load_stackoverflow)
IT (1) IT1009527B (enrdf_load_stackoverflow)
NL (1) NL7309257A (enrdf_load_stackoverflow)
NO (1) NO146338C (enrdf_load_stackoverflow)
SE (3) SE440697B (enrdf_load_stackoverflow)
SU (1) SU581842A3 (enrdf_load_stackoverflow)
ZA (1) ZA734632B (enrdf_load_stackoverflow)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2840039A1 (de) * 1978-04-28 1979-11-08 Wistar Inst Verfahren zur erzeugung von tumor- antikoerpern

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4132769A (en) * 1974-10-30 1979-01-02 Osther Kurt B Cancer antigen, cancer therapy, and cancer diagnosis
US4146603A (en) * 1977-02-18 1979-03-27 Research Corporation Tumor specific glycoproteins and method for detecting tumorigenic cancers
JPS56145297A (en) * 1980-04-11 1981-11-11 Kureha Chem Ind Co Ltd Preparative method of glycoprotein having immunosupressing activity
EP0087898A1 (en) * 1982-02-22 1983-09-07 Cancer Research Campaign Technology Limited Antibodies and antigens useful in the diagnosis and treatment of cancer

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Int. Arch. Allergy 36, 191-194, 1968 *
J. Exp. Med. 121, 439-441, 1965 *
KABAT, E.A.: Einführung in die Immunchemie und Immunologie, S.28-29, Springer-Verlag 1971 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2840039A1 (de) * 1978-04-28 1979-11-08 Wistar Inst Verfahren zur erzeugung von tumor- antikoerpern

Also Published As

Publication number Publication date
FI60567C (fi) 1982-02-10
SE440697B (sv) 1985-08-12
SE440597B (sv) 1985-08-12
IL42594A0 (en) 1973-08-29
BE802126A (fr) 1973-11-05
DD113918A5 (enrdf_load_stackoverflow) 1975-07-05
GB1443054A (en) 1976-07-21
DE2333740A1 (de) 1974-01-31
SE7609837L (sv) 1976-09-06
AR197243A1 (es) 1974-03-22
CA1039650A (en) 1978-10-03
ATA600773A (de) 1976-09-15
NL7309257A (enrdf_load_stackoverflow) 1974-01-14
NO146338B (no) 1982-06-01
SE7609836L (sv) 1976-09-06
JPS4955823A (enrdf_load_stackoverflow) 1974-05-30
NO146338C (no) 1982-09-08
JPS56115954A (en) 1981-09-11
DK139898B (da) 1979-05-14
SE418186B (sv) 1981-05-11
JPS5817168B2 (ja) 1983-04-05
CH617853A5 (en) 1980-06-30
AT336780B (de) 1977-05-25
GB1443053A (en) 1976-07-21
ES416726A1 (es) 1976-06-16
IL42594A (en) 1976-08-31
SU581842A3 (ru) 1977-11-25
DK139898C (enrdf_load_stackoverflow) 1979-10-08
FI60567B (fi) 1981-10-30
DE2333740C2 (de) 1987-01-22
DD118946A5 (enrdf_load_stackoverflow) 1976-03-20
FR2191885A1 (enrdf_load_stackoverflow) 1974-02-08
AU5728673A (en) 1975-01-09
BR7305142D0 (pt) 1974-08-22
IN138903B (enrdf_load_stackoverflow) 1976-04-10
FR2191885B1 (enrdf_load_stackoverflow) 1977-07-01
IT1009527B (it) 1976-12-20
JPS6018011B2 (ja) 1985-05-08
ZA734632B (en) 1974-06-26

Similar Documents

Publication Publication Date Title
DE2029499C3 (de) Verfahren zum Nachweis der Anwesenheit von carcinoembryonalen Antigenen im Blut
CH634334A5 (de) Neues glycoprotein und verfahren zu dessen herstellung.
CH640140A5 (de) Verfahren zur herstellung von intravenoes injizierbarem gamma-globulin.
DE2127159C2 (de) IgG-Immunglobulinfraktion und ihre Herstellung
EP0009715B1 (de) Neues ubiquitäres Gewebsprotein PP8 und Verfahren zu seiner Anreicherung
DE2640387C3 (de) Gewebespezifisches Protein und Verfahren zu dessen Herstellung
EP0101063B1 (de) Neues Polypeptid mit Wirkung auf das Immunsystem, Verfahren zu seiner Isolierung und Reinigung, seine Verwendung und dieses enthaltende Mittel
DE2366609C2 (enrdf_load_stackoverflow)
DE68911693T2 (de) Pharmazeutisches mittel für behandlung von menschlichem krebs und verfahren zu seiner herstellung.
CH659586A5 (de) Arzneimittel aus dem thymus und verfahren zu dessen herstellung.
WO1997034929A1 (de) Verfahren zur gewinnung eines komplexes aus wachstumsfaktoren
DE2857532C1 (de) Therapeutisches Mittel zur Wundbehandlung und Verfahren zu seiner Herstellung
DE1617332C3 (de) Verfahren zum Isolieren eines wasserlöslichen Protein-Metall-Chelats mit antiphlogistischer Wirkung
SU624562A3 (ru) Способ получени вещества, обладающего гормональным действием
DE3306944A1 (de) Fibrinolytisch aktives mittel und verfahren zu seiner herstellung
CH634854A5 (de) Verfahren zur herstellung organopeptidhaltiger substanzen mit insulinaehnlicher wirksamkeit aus blut oder blutbestandteilen.
EP0075925B1 (de) Verfahren zur Herstellung eines spezifisch auf das Ernährungszentrum wirkenden appetitregelnden Wirkstoffes sowie der nach diesem Verfahren erhältliche Wirkstoff
DE3742139A1 (de) Praeparat zur physiologischen regulierung des neuroendokrinen systems, stimulierung der immunitat, wachstumshemmung von hormonabhaengigen geschwulsten und verfahren zur herstellug des genannten praeparates
EP0107782A1 (de) Verfahren zur Isolierung von Relaxin
DE2062558A1 (de) Mittel zur Diagnose von primärem Leberkrebs und Verfahren zur Her stellung desselben
DE2815758C3 (de) Peptidkomplexe aus DNS-haltigen Organismen
DE3334405A1 (de) Membranassoziierte proteine (mp(pfeil abwaerts)2(pfeil abwaerts)), verfahren zu ihrer gewinnung sowie ihre verwendung
Bauer Studies on Isolated Keratin Fractions from Mammalian Epidermis: I. Physicochemical Properties of the Fractions
DE1767099B1 (de) Verfahren zur Gewinnung eines Glykoproteins mit einer Hemmwirkung gegenueber Magensaeureabsonderung und einer Antiaktivitaet gegenueber Ulcus-Bildung
EP0396597A1 (de) Verfahren zur herstellung eines therapeutisch aktiven, insbesondere zur wundheilung oder zur behandlung in der geriatrie verwendbaren wirkstoffes und ein einen solchen wirkstoff enthaltendes therapeutisches präparat

Legal Events

Date Code Title Description
Q172 Divided out of (supplement):

Ref country code: DE

Ref document number: 2333740

8110 Request for examination paragraph 44
8181 Inventor (new situation)

Free format text: BJOERKLUND, KNUT BERTIL, DR.MED., BROMMA, SE

AC Divided out of

Ref country code: DE

Ref document number: 2333740

Format of ref document f/p: P

D2 Grant after examination
8364 No opposition during term of opposition